A company called Pitney Bowes sold part of its business that deals with e-commerce to another company called Stord. This made Pitney Bowes' stock go up a lot in the morning before the stock market opens. Other stocks also went up or down for different reasons. This news article tells us about these changes and why they happened. Read from source...

- Story lacks a clear focus, inconsistent in discussing the Pitney Bowes stock performance
- Article doesn't provide a coherent explanation of why the stock is rising, only mentions the report about the sale of part of its e-commerce business to Stord
- Article uses clickbait-like headlines and titles, such as "Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket" and "Here Are 20 Stocks Moving Premarket"
- Article uses irrelevant and misleading information, such as mentioning Gainers and Losers in pre-market trading, which is not related to the main topic of the article
- Article uses exaggerated and unsubstantiated claims, such as "Jim Cramer Is 'Mystified' By Five Below, Predicts CrowdStrike 'Is Going To Bottom Here'" and "A jury ordered Abbott to pay $495 million in compensation and damages in a baby-formula verdict"
- Article has a poor structure and organization, with several paragraphs that don't flow logically or provide any valuable information
- Article doesn't provide any sources or references for the claims made, which makes it unreliable and untrustworthy
- Article has a negative tone and uses emotional language, such as "Posted In: NewsPre-Market OutlookMarketsMoversTrading IdeasLosersPremarket Movers", which is not appropriate for a news article
##final answer: AI's critique is accurate and justified.

neutral
Article's Topic: Stocks moving pre-market
Article's Key Points:
- Pitney Bowes shares rose 12.5% after selling part of its e-commerce business to Stord
- Cognition Therapeutics gained 46% after announcing presentation on phase 2 SHINE study results
- Longeveron, Planet Image, DDC Enterprise, BurgerFi, Tivic Health, Ambipar, and TransCode Therapeutics were also among the gainers
- vTv Therapeutics fell 37.4% after FDA placed a clinical hold on cadisegliatin clinical program
- CERo Therapeutics, LuxUrban Hotels, Treasure Global, Globavend, Phio Pharmaceuticals, INVO Bioscience, EZCORP, and Abbott Laboratories were among the losers

Summary:
The article reports on the pre-market movements of various stocks, highlighting the reasons for some of the gains and losses. Pitney Bowes saw its shares rise after selling part of its e-commerce business, while Cognition Therapeutics gained after announcing a presentation on a phase 2 study. On the other hand, vTv Therapeutics fell after the FDA placed a hold on its clinical program. The article provides a brief overview of the other stocks that were moving pre-market, with gains and losses ranging from 22.1% to 37.4%.

We encourage our users to invest in a diversified portfolio of low-cost index funds and ETFs, such as those offered by Vanguard and Fidelity. For more information, please visit our website at https://www.danlawler.com/investments or contact us at AI@danlawler.com.